Vaccines

13 Jan 2009 Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
13 Jan 2009 Cytos Biotechnology presents analysis of patient diaries including six month follow-up data from phase II study with CYT003-QbG10 monotherapy for the treatment of allergic diseases
09 Jan 2009 Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL(R) in Women Ages 27 through 45
08 Jan 2009 Juvaris BioTherapeutics Announces Positive Data from Clinical Trial of JVRS-100 Adjuvanted Flu Vaccine
08 Jan 2009 Altus Pharmaceuticals Successfully Completes Phase 1 Study of Long Acting Formulation of Recombinant Human Growth Hormone
07 Jan 2009 Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment
06 Jan 2009 Advaxis Phase II Clinical Trial HOLD Lifted
06 Jan 2009 MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
05 Jan 2009 CureVac Receives IND Approval from the FDA to start its Phase I/IIa mRNA Vaccine Clinical Trial in Prostate Cancer
29 Dec 2008 Product Development Update: Intercell starts Phase II clinical trial for Pseudomonas aeruginosa vaccine and FDA approval of IXIARO(R) expected in early 2009
29 Dec 2008 Novartis strengthens vaccine pipeline with agreement for novel CMV vaccines candidate
24 Dec 2008 Biocompatibles and AstraZeneca sign Diabetes Drug Agreement
23 Dec 2008 Nabi Biopharmaceuticals Reaches Special Protocol Agreement With FDA for NicVAX(r) Phase 3 Trial Protocol
23 Dec 2008 ImmunoCellular Therapeutics Cancer Vaccine Demonstrates Immune Response against Brain Cancer in Clinical Trial
19 Dec 2008 Emergent BioSolutions Receives FDA Approval for BioThrax Supplemental Biologics License Application
19 Dec 2008 Dynavax Announces Termination of Partnership With Merck for HEPLISAV(TM) Hepatitis B Vaccine
19 Dec 2008 Intercell update on technology partnerships: Intercell outlicenses Group B Streptococcus vaccine
18 Dec 2008 Merck KGaA acquires manufacturing rights for Stimuvax from Oncothyreon
18 Dec 2008 INTANZA(R) / IDflu(R), first intradermal influenza vaccine recommended in the European Union
18 Dec 2008 Baxter Receives EMEA Positive Opinion for CELVAPAN, The First Cell Culture-Based Pandemic Flu Vaccine
17 Dec 2008 Nabi Biopharmaceuticals Enters Clinical Initiative With US Military to Advance PentaStaph(tm)
16 Dec 2008 ICLL: Positive opinion for approval of Japanese Encephalitis vaccine in Europe
15 Dec 2008 Hawaii Biotech Completes Dosing of Phase 1 Trial for West Nile Virus Vaccine
11 Dec 2008 Barr's BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
11 Dec 2008 Intercell AG wins the Scrip Award for Biotech Company of the Year

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top